Cadila Healthcare’s US subsidiary has received approval forΒ anti-obsessional drug, from the US health regulator. In a filing the company stated that, Zydus Pharmaceuticalst (USA) Inc,...
Lupin has received final approval forΒ Calcipotriene Topical Solution, 0.005% (Scalp Solution), from USFDA. The company has received approval to market a generic version of Dovonex...
Dr Reddy’s Laboratories has received approval from the US health regulator for drug that reduces bloodΒ phenylalanine concentrations in patients. It has received tentative approval from...
The US health regulator has given approvalΒ to Aurobindo Pharma, for manufacturing and marketing generic version ofΒ Fondaparinux Sodium injection, which is used to prevent deep vein...
The US health regulator has given final approval to Glenmark Pharmaceuticals for a generic version of Minastrin 24 tablets, which is used to prevent pregnancy....
The US health regulator has accepted a new drug application (NDA) for an ophthalmic solution, which was filed by Sun Pharma’s wholly owned subsidiary. In...
Alembic Pharmaceuticals associate company Rhizen Pharmaceuticals has received approval from USFDA for cancer drug. According to a BSE release, “Rhizen Pharmaceuticals S.A. today announced that...
Zydus Pharmaceuticals (USA) Inc, a wholly owned subsidiary of Cadila Healthcare, has got final approval from theΒ US Food and Drug Administration to market Nifedipine extended...
Morepen Laboratories has received USFDA clearance for its bulk drug Montelukast Sodium. The company stated, “This gives Morepen an entry into the Rs.2,000 crore (approximately...
Lupin has received approval from theΒ US health regulator, for Tydemy drug that is used to prevent pregnancy. The companyΒ has receivedΒ final approval for itsΒ Tydemy (Drospirenone, Ethinyl...